Abstract: Background. Head and neck squamous cell carcinoma (HNSCC) is a devastating disease usually diagnosed at a late stage when cure rates are 40%. We examined a simple and inexpensive molecular tool that may aid HNSCC detection.
skill-dependent, and cannot detect occult disease. There are diagnostic kits available for oral cancer such as OralCDx Brush Biopsy (OralCDx Laboratories, Suffern, NY), ViziLite Plus (Zila Pharmaceuticals, Phoenix, AZ) and toluidine blue. Even though these tests can assist in the identification of abnormalities, they require an experienced professional to interpret the results and follow-up visits for a more definitive test such as a biopsy. 9 These facts may explain why, despite the American Cancer Society and National Cancer Institute's emphasis that oral examinations could prevent many deaths, few individuals receive these examinations. [10] [11] [12] Because screening by physical examination has these limitations, researchers have turned to molecular markers for solutions. Much of the work on HNSCC tumor markers performed in serum has been replicated in whole unstimulated saliva or oral rinses. [13] [14] [15] [16] [17] [18] [19] [20] Spafford et al 13 showed loss of heterozygosity or microsatellite instability in 1 of 23 markers in 79% of saliva samples from 44 patients with HNSCC and in none of 43 healthy control subjects. In a cohort including 211 patients with HNSCC and 527 normal control subjects, methylation-specific marker panels in salivary rinses improved detection when compared with single markers, including a panel with 35% sensitivity and 90% specificity and a panel with 85% sensitivity and 30% specificity. 20 Telomerase activity has also been studied using a polymerase chain reaction-based assay in which activity was found in 80% of patients with HNSCC and 5% of control subjects. 21 At the RNA level, salivary transcriptome profiling 16 and most recently microRNAs (miRNAs) [22] [23] [24] [25] [26] [27] have been used for HNSCC biomarker discovery. Wong's group used microarray followed by quantitative polymerase chain reaction analysis of miRNA in saliva and showed that a panel of 4 markers detects HNSCC with 91% sensitivity and 91% specificity. 16 High-throughput technology is also used to identify salivary miRNAs as putative biomarkers for oral cancer detection. Most often, miRNAs are tested in tumor samples yielding very high sensitivity and specificity 22, 25 for disease prediction. Recently, Park et al 17 detected dozens of miRNAs in saliva and found miR-125a and miR-200a to be present at significantly lower levels (p < .05) in oral squamous cell carcinoma than in control subjects.
Proteomic analysis of saliva has provided good results when studying cytokines as candidate biomarkers for HNSCC. Cytokines are soluble proteins involved in immune and inflammatory responses and have been studied in serum 28 and saliva 15, 18 for immune-based biomarker discovery. More recently, a new screening tool using multiplexed immunobeadbased technology (Luminex Corporation, Austin, TX) has been tested in serum and saliva of patients with HNSCC. 19, 29 Linkov et al, 29 utilizing serum samples, identified a panel comprised of 25 markers including interleukin-8, epidermal growth factor, and epidermal growth factor receptor that offered 84.5% sensitivity and 98% specificity.
Although these studies show promise, in many cases they do not fulfill the ideal characteristics of a screening test, because they are relatively expensive to perform, require considerable expertise, and are not widely available. Furthermore, no molecular screening method for HNSCC has been validated in large studies.
Our data show that a simple, inexpensive oral rinse test shows promise for detecting HNSCC. We have found that the marker soluble CD44 (solCD44) was able to distinguish patients with HNSCC from control subjects with 62% to 79% sensitivity and 88% to 100% specificity. 30, 31 Although in our prior work we tested total protein levels as a potential normalizer for solCD44 levels, 31 we were surprised to find that total protein levels were, in fact, elevated in cancer cases compared to control subjects. In this report, we further investigated salivary protein levels in oral rinses to (1) determine the relationship between total protein levels and important risk and demographic variables, (2) compare results for total protein and solCD44, and (3) analyze whether the combination of salivary protein plus solCD44 is a better marker for HNSCC than either marker alone.
MATERIALS AND METHODS
Subject Characteristics. One hundred two patients with HNSCC and 84 control subjects (15 healthy volunteers, 69 patients with benign diseases of the upper aerodigestive tract, and 59% smokers) were enrolled according to the protocol approved by the University of Miami Institutional Review Board. We used the same cohort as previously described. 31 To enroll a control population with tobacco and alcohol exposure similar to the patient population with HNSCC, control subjects from otolaryngology clinics were approached if they answered ''yes'' to tobacco or alcohol use on the clinic intake questionnaire. Control subjects were excluded if they had a potentially malignant condition or if final diagnosis of their condition was unknown. One control subject was excluded when, in follow-up, the subject developed a dysplastic lesion. Healthy control subjects were volunteers from healthcare and research fields. All patients with HNSCC had biopsy-proven, newly diagnosed, or recurrent squamous cell carcinoma. We included all stages and sites except nasopharynx, because nasopharyngeal carcinoma tends to behave differently compared to HNSCC in other sites. Five patients with HNSCC had cervical lymph node disease but no identified mucosal primary cancer. Subjects who were known to be pregnant or infected with the human immunodeficiency virus were excluded.
Oral Rinse Collection. The oral rinse collection procedure was previously described. 31 Five milliliters of normal saline was placed in the subject's mouth. Patients were asked to swish for 5 seconds, gargle for 5 seconds, and then deposit the oral rinse into a specimen cup. Saliva was placed on ice for transport and stored at À80 degrees.
Protein Assay. Total protein concentration in oral rinse specimens was determined in our prior study 31 using the BioRad Protein Assay (BioRad, Hercules, CA), as previously described. 30, 31 For each specimen, protein estimation was carried out at 3 dilutions and each dilution was assayed in triplicate to calculate the average protein concentration (mg/mL).
Soluble CD44 Assay. solCD44 concentration in oral rinse specimens was determined in our previous study. 31 Briefly, we measured levels of solCD44 using an enzyme-linked immunosorbent assay assay (Bender MedSystems, Vienna, Austria) that recognizes all CD44 normal and variant isoforms. The test involves a sandwich-type enzyme-linked immunosorbent assay using a monoclonal anti-solCD44 antibody. Sample concentrations were determined by a standard curve. We optimized the test for oral rinses by preparing the standards in a synthetic saliva matrix (Salimetrics, State College, PA) diluted 1:5 in normal saline (because patients swished and gargled with 5-cc saline) and used a sample diluent (Salimetrics) developed for saliva samples. Samples were vortexed, centrifuged at 3000 Â g, and the supernatant was used for study. We performed the test at full, 1:2, and 1:4 dilutions. All sample assays were performed in triplicate.
Statistical Analysis. In our previous work, we analyzed solCD44 with respect to important risk and demographic variables. Although we showed that higher total protein levels were associated with case status, we did not investigate total protein as a potential marker for HNSCC in combination with solCD44.
In this work, we analyzed the association of solCD44 and total protein levels and (1) risk factor and demographic covariates within and between the 2 groups (cancer cases and benign disease controls), and (2) tumor characteristics within the cancer group. The inclusion of solCD44, which was previously reported using a somewhat different analysis, 31 permits comparison of the 2 markers with respect to the important risk factors and demographics.
Patients who were most recently accrued completed a questionnaire containing information on tobacco and alcohol exposure, race, ethnicity, sex, and socioeconomic status. We used t tests to analyze data for 2 categories and analysis of variance for 3 or more categories. Tobacco was analyzed by 2 methods. In the first method, we compared current, former, and never smokers. A subject was categorized as a current cigarette smoker if they smoked any amount of cigarettes a day, a former smoker if they smoked at least 100 cigarettes in their lifetime, but smoked 0 cigarettes per day presently, and a never smoker if they never smoked at least 100 cigarettes in their lifetime. In the second method, we compared those who ever used a tobacco product to those who never used a tobacco product. Subjects were categorized as ever tobacco users if they smoked at least 100 cigarettes or ever smoked tobacco in a pipe or cigar or chewed smokeless tobacco. Alcohol use was categorized by drinking level. Subjects who drank no alcoholic beverages in a month were nondrinkers. Those who drank 1 to 15 days per month and had 1 to 3 beverages on the days they drank were light drinkers. Those who drank 1 to 5 days per month and 4 or more beverages on the days they drank or 16 to 30 days per month and 1 to 3 beverages on the days they drank were categorized as moderate drinkers. Heavy drinkers drank 16 to 30 days per month and 4 or more alcoholic beverages on the days they drank.
Logistic regression analysis was used to assess the effect of total protein and solCD44 on the risk for HNSCC using both continuous and categorical measurements. For continuous measurements, solCD44 data was log base-2 transformed because data were positively skewed to the right. For the categorical representation of data, protein levels were categorized as high or low based on the median of the control group. A multivariate adaptive regression splines (MARSs) model, as previously described 32 was used to identify the optimal cut points for solCD44. MARS software (Salford Systems, San Diego, CA) estimates splinebased models to construct a logistic regression analysis using Statistical Package for the Social Sciences (SPSS) software (IBM, Chicago, IL). Model-derived estimates of sensitivity, specificity, and accuracy are reported. Table 1 summarizes the demographic and risk factor data for cases and controls and solCD44 and protein levels for each group (controls and HNSCC). We have previously described that both solCD44 and total protein levels are significantly elevated in patients with HNSCC compared to controls. 31 Within the control group, a significant association was found between mean protein level and sex (p ¼ .004), with higher protein levels found in men. Results for solCD44 similarly showed higher levels for men but did not reach significance. There was a trend toward higher solCD44 levels in current smokers and subjects with 6 or more teeth missing in the control group. Our results show that solCD44 levels in oral rinses are significantly higher in cases versus controls for the former smoker category (p ¼ .01) but not for the current smoker category (p ¼ .87). Because smoking is associated with increased HNSCC risk and this risk begins to decrease as early as 1 year after smoking cessation, [33] [34] [35] we believe the finding of lower solCD44 levels in former smokers is related to their decreased risk for HNSCC compared to current smokers. Within the cancer group, there were no significant associations between protein and solCD44 levels and any of the risk factors or demographic variables evaluated. In general, protein and solCD44 levels were higher in cases than controls regardless of demographics or risk factor behaviors. Most instances in which significance was not reached was likely due to very small numbers (n < 10) of subjects within at least 1 of the categories analyzed. Analysis of maximum likelihood estimates showed no significant interaction between solCD44 and protein.
RESULTS
To investigate the effects of tobacco use further, we developed box plots of protein and solD44 levels in 5 groups of study subjects with different case/control or smoking status: 1 ¼ healthy, nonsmoking volunteer (n ¼ 10), 2 ¼ nonsmoker controls with benign disease or quit >6 months ago (n ¼ 48), 3 ¼ smoker controls with benign disease or quit <6 months ago (n ¼ 13), 4 ¼ patients with HNSCC nonsmokers or quit >6 months ago (n ¼ 18), and 5 ¼ patients with HNSCC who were smokers or quit <6 months ago (n ¼ 24). A global test of the 5 means in Figure 1 shows a statistically significant difference for solCD44 (p ¼ .0417) and protein (p ¼ .0001). For both solCD44 and total protein, case smokers did not differ from case nonsmokers and smoker controls did not differ from nonsmokers. The data illustrate that the 3 groups of controls have very similar distribution of protein and solCD44 levels irrespective of presence of benign disease or history of smoking. Similarly, the 2 groups of cases also have a very similar distribution of protein and solCD44 levels. Therefore, combined data from 3 groups of controls and 2 groups of cases were used for case-control comparison.
We also evaluated whether the protein and solCD44 levels differ by tumor characteristics (Table 2) . Five subjects with disease in the cervical lymph nodes and no identified primary site were excluded. Protein levels differed by tumor site (p ¼ .048), with the only significant pairwise comparison being between oropharynx and larynx/hypopharynx. Likewise, solCD44 levels differed significantly by tumor site (p ¼ .022); in this case, the only significant pairwise comparison was between oral cavity and larynx/hypopharynx. The differences in protein and in solCD44 between oral cavity and oropharynx groups were not significant at the 5% significance level.
The categorical assessment revealed that higher levels of protein (!0.4325 mg/mL) or solCD44 (!8.84 ng/mL) was significantly associated with HNSCC (Table 3) . HNSCC was significantly associated with high levels of both solCD44 (>14.56 ng/mL) and protein (!0.4325 mg/mL; odds ratio [OR] ¼ 24.90; 95% confidence interval [CI] ¼ 9.04-68.57; Table 3 ). The area under the curve (AUC; 0.786) was better when the markers were combined in multivariate analysis compared to univariate analysis. Sensitivities and specificities derived from various predicted probability cut points based on the bivariate model were summarized in Table 3 .
When continuous measurements were used, univariate and multivariate logistic regression resulted in receiver operating characteristic curves with AUC as shown in Table 4 . In univariate analysis, for every 2-fold increase in solCD44, there was a 2.20-fold (95% CI ¼ 1.66-2.93) increased risk for HNSCC; for every unit increase of protein, there was a 5.82-fold (95% CI ¼ 2.80-12.13) increased risk for HNSCC. In bivariate analysis, the adjusted OR for solCD44 and protein was 1.86 (95% CI ¼ 1.38-2.50) and 3.10 (95% CI ¼ 1.47-6.52), respectively. The model including solCD44 and protein presented the best AUC value at 0.796. Sensitivities and specificities derived from various predicted probability cut points based on the bivariate model were summarized in Table 4 . Best accuracy was obtained using a predictive probability cut point of 0.47, with corresponding estimates of sensitivity and specificity 80.4 and 65.5, respectively. 
DISCUSSION
Our previous work shows that solCD44 can distinguish patients with HNSCC from controls with 62% sensitivity and 88% specificity. 31 However, our prior work did not include analysis of total protein as a potential marker for HNSCC. Our results in this work indicate that subjects with high solCD44 and protein levels in the oral rinse are almost 25 times more likely to have cancer than those without these elevated levels. This association of the combined markers with cancer is much stronger than that of total protein alone (OR ¼ 5.00, 95% CI ¼ 2.55-9.81) or solCD44 alone (OR ¼ 12.43, 95% CI ¼ 5. 40-28.61 ). This is supported by the receiver operating characteristic analysis which shows a higher AUC value of 0.796 with the combination of solCD44 and protein compared to either marker alone. Because the solCD44 and protein tests are very simple and inexpensive, this combination may be useful for early diagnosis of HNSCC.
This work also shows for the first time that protein levels were elevated regardless of tumor size or stage, indicating that these markers are present early in carcinogenesis. Furthermore, 82% of the 84 control subjects had benign diseases of the upper aerodigestive tract. Thus, the elevated protein level seems to distinguish cancer from benign disease. Hydration level does not seem to have a great impact on results for the oral rinse technique. Patients with small T1 lesions are not expected to have swallowing difficulties and thus should have similar hydration status as the control patients, yet the oral rinse protein levels of patients with T1 lesions were still elevated compared to control subjects.
Site seems to play an important role in protein and solCD44 levels, with larynx and hypopharynx having lower levels than oral cavity and oropharynx. However, marker levels are not different by tumor stage, nodal status, recurrence status, or history of second primary. Human papillomavirus (HPV) confers an increased risk to head and neck cancer, especially cancer of the oropharynx. Although we did not have HPV status information for our patients, we did analyze results based on tumor site (Table 2) . For solCD44, levels were significantly higher for oral cavity compared to larynx/hypopharynx. For protein, levels were significantly higher for oropharynx compared to larynx/hypopharynx. Therefore, although HPV may have an effect for protein, it does not seem to have an effect for solCD44.
Elevated protein levels in salivary rinses from patients with HNSCC may be partly due to overexpression of numerous soluble proteins. Smith et al 36 showed global hypomethylation, in HNSCC tumor tissues compared to normal mucosa tissues. Such hypomethylation would be expected to result in an overall increase in protein expression in HNSCC. Indeed, Hu et al 18 identified a group of 5 proteins that in combination were useful for detecting HNSCC. Although global overexpression of tumor-associated proteins is possible, it is also likely that tumors, being highly vascular, promote leaking of proteins such as albumin and immunoglobulin G from the serum into the oral rinse, as has been suggested by the work of Shpitzer et al. 37 The high levels of protein that we see, in the mg/mL range, suggest that this may be the case because tumor markers are generally expressed in the ng/mL range.
Saliva is becoming the biologic sample of choice for head and neck cancer screening. 38 It can be obtained simply and less invasively than blood and thus can be collected without special training. In general, there are 3 methods for collecting saliva. These include salivary rinses, whole saliva, and stimulated saliva. Our laboratory is studying soluble molecular markers for HNSCC using oral rinses. The patient swishes with 5 cc saline for 5 seconds, gargles the rinse for 5 seconds, and then expectorates into a collection cup. Although the oral rinse does contain whole saliva, it also results in a specimen that has Table 3 . Categorical assessment of solCD44 (ng/mL) and total protein (mg/mL) as molecular predictors of HNSCC. had optimal contact with all regions of the upper aerodigestive tract compared to whole saliva or stimulated saliva, which only permits contact with the anterior oral cavity. Furthermore, concentrations of whole saliva components can vary greatly with hydration level. Because there is more contact with surfaces that contain secreted proteins, it is quite possible that the relative protein composition of the oral rinse would be different and perhaps more favorable than that of whole or stimulated saliva. This may explain why we see significantly higher total protein levels in patients with HNSCC compared to controls when using the oral rinse, whereas we and other researchers did not see a significant difference when using other sampling methods. 15 Ongoing work is investigating the associations between specific risk factors and demographics with protein and solCD44 levels. Our data show that protein levels are significantly higher in male control subjects compared to female control subjects. Further investigation is needed to verify this finding and to determine if other demographic and risk variables are associated with marker levels. Our data here suggest a trend toward association between higher solCD44 levels and current tobacco use and poor oral health in controls, although our analyses did not reach statistical significance. As can be inferred by the large SD, most of the elevation seen in current smokers in the control group is due to a few subjects with very high levels. Thus, it is possible that the test is identifying very early disease, as has been described in previous work. 31 This is not surprising because both tobacco use and poor oral health are risk factors for HNSCC. 39, 40 Approximately 20% of American still smoke and many more millions drink heavily or are exposed to HPV, therefore, a very simple and inexpensive test is needed to identify those individuals who are likely to have HNSCC or premalignant disease. Because it is simple, inexpensive, noninvasive, and seems to be effective, we envision that a test including combined measurements of solCD44 or total protein would serve this purpose. Subjects with combined results above a predetermined cut point would be referred to a specialist for examination and a biopsy. Subjects with cancer or precancer would be treated with standard of care. Subjects without lesions could be followed closely with oral rinse tests and physical examination and encouraged to stop risky behavior such as smoking. Our prior work suggests that the test may identify disease before it becomes clinically visible. 31 Because premalignant lesions are known to reverse with smoking cessation, 41 even in the case of a positive rinse test and no identifiable lesion, the subject may be encouraged to modify their behavior in a positive manner. This may result in a reversal of marker levels and diminished risk of disease. Further work is underway to determine whether solCD44 levels change with smoking cessation and whether subjects are likely to change risky behavior based on an oral rinse test result.
In summary, in this study of 102 patients with HNSCC and 84 control subjects, oral rinse protein levels are significantly associated with HNSCC. Patients with high levels of solCD44 and protein are nearly 25 times more likely to have HNSCC than subjects without levels in this range. Our statistical models suggest that the combination of solCD44 and total protein will improve sensitivity and specificity of the HNSCC detection test compared to either marker alone. Our ongoing work will examine these findings further in a larger matched case-control study.
